$0.83
+0.02 (+2.56%)
Open$0.82
Previous Close$0.81
Day High$0.86
Day Low$0.80
52W High$25.81
52W Low$19.95
Volume—
Avg Volume222.0K
Market Cap13.36M
P/E Ratio18.79
EPS$1.30
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+3,822.0% upside
Current
$0.83
$0.83
Target
$32.58
$32.58
$17.80
$32.58 avg
$40.39
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.19M | 1.96M | 2.40M |
| Net Income | -647,190 | -493,473 | -738,397 |
| Profit Margin | -29.6% | -25.2% | -30.8% |
| EBITDA | -712,204 | -583,546 | -705,797 |
| Free Cash Flow | -781,686 | -525,232 | -735,953 |
| Rev Growth | +18.0% | +10.8% | +10.6% |
| Debt/Equity | 0.28 | 0.23 | 0.30 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |